Sepsis marker | Evaluated in experimental studies | Evaluated in clinical studies | Evaluated as a prognostic factor | Comment |
---|---|---|---|---|
 | C | √* | Distinguished between survivors and non-survivors at 28 days | |
 | B | √** | Distinguished between survivors and non-survivors at 28 days, correlated to APACHE II score | |
Carbomyl phosphate synthase (CPS)-1 [173] | √ |  |  |  |
√ | B | √ | Distinguished between survivors and non-survivors at 28 days, correlated with SOFA score | |
Filterable cardiodepressant substance (FCS) [178] | √ |  |  |  |
Gc-globulin [179] | Â | C(s) | Â | Predicted development of MOF |
Glial fibrillary acidic protein (GFAP) [180] |  | B | √ | Increased in septic shock compared with healthy controls |
alpha glutathione S-transferase (GST) [181] | √ |  |  |  |
Hepatocyte growth factor (HGF) (cellular and soluble) [182, 183] | √ | C(m) |  | Predicted response to therapy |
√ | A | √ | Correlated with SAPS II score | |
Myocardial angiotensin II [186] | √ |  |  |  |
NSE [187] |  | B | √ | Correlated with SOFA scores |
Pancreatitis-associated protein-I [188] | √ |  |  |  |
Pre B cell colony-enhancing factor (PBEF) [189] | Â | A | Â | Increased in sepsis compared with healthy controls |
√ | B | √ | Distinguished between survivors and non-survivors at 28 days, correlated with SOFA score | |
√ | A |  | Increased in sepsis compared with healthy controls | |
Troponin [193] |  | B | √ | Distinguished between survivors and non-survivors at 28 days, correlated with APACHE II score |